Indian Journal of Respiratory Care

IJRC Email      Register      Login

VOLUME 13 , ISSUE 3 ( July-September, 2024 ) > List of Articles

CASE REPORT

Fungal Pneumonia in an Immunocompetent Host: A Case Report

Sailaja Kambhampati, G K Anitha Patil, Kalpana Gundapu

Keywords : Antifungals, Aspergillus fumigatus, Case report, Hypokalemia, Immunocompetent

Citation Information : Kambhampati S, Patil GK, Gundapu K. Fungal Pneumonia in an Immunocompetent Host: A Case Report. Indian J Respir Care 2024; 13 (3):206-211.

DOI: 10.5005/jp-journals-11010-1129

License: CC BY-NC 4.0

Published Online: 30-09-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Abstract

Aspergillus fumigatus is an opportunistic fungus, found ubiquitously in the environment. A. fumigatus typically infects an immunocompromised host. This case report is about a 55-year-old immunocompetent woman who was initially treated with antibiotics after being diagnosed with a pulmonary infection. However, further investigations revealed fungal pneumonia due to A. fumigatus. The patient eventually responded to antifungal treatment, although adverse effects of the antifungals were observed. Despite its rarity, it is important to consider other differential diagnoses, such as fungal pneumonia, if the pneumonia does not respond to medical treatment, as well as the potential adverse effects of antifungals.


PDF Share
  1. Agustí C, Rañó A, Aldabó I, et al. Fungal pneumonia, chronic respiratory diseases and glucocorticoids. Medical Mycology 2006;44(Suppl 1):S207–S211. DOI: 10.1080/13693780600857348
  2. Ahmed MM, Farghaly AA, Raafat RH, et al. Study of the prevalence and pattern of fungal pneumonias in respiratory intensive care units. Egypt J Bronchol 2019;13:545–550. DOI: 10.4103/ejb.ejb_37_19
  3. Burton L, Baumgart K, Novakovic D, et al. Fungal pneumonia in the immunocompetent host: a possible statistical connection between allergic fungal sinusitis with polyposis and recurrent pulmonary infection detected by gastroesophageal reflux disease scintigraphy. Mol Imaging Radionucl Ther 2020;29(2):72–78. DOI: 10.4274/mirt.galenos.2020.32154
  4. Cadena J, Thompson GR 3rd, Patterson TF. Aspergillosis: epidemiology, diagnosis, and treatment. Infect Dis Clin North Am 2021;35(2):415–434. DOI: 10.1016/j.idc.2021.03.008
  5. Clancy CJ, Nguyen MH. Acute community-acquired pneumonia due to Aspergillus in presumably immunocompetent hosts: clues for recognition of a rare but fatal disease. Chest 1998;114(2):629–634. DOI: 10.1378/chest.114.2.629
  6. Eiden C, Peyrière H, Cociglio M, et al. Adverse effects of voriconazole: analysis of the French Pharmacovigilance Database. Ann Pharmacother 2007;41(5):755–763. DOI: 10.1345/aph.1H671
  7. Kosmidis C, Denning DW. The clinical spectrum of pulmonary aspergillosis. Thorax 2015;70(3):270–277. DOI: 10.1136/thoraxjnl-2014-206291
  8. Latgé JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 1999;12(2):310–350. DOI: 10.1128/CMR.12.2.310
  9. Mackel JJ, Steele C. Host defense mechanisms against Aspergillus fumigatus lung colonization and invasion. Curr Opin Microbiol 2019;52:14–19. DOI: 10.1016/j.mib.2019.04.003
  10. Yang W, Ma Y, Wang J, et al. Fungal pneumonia manifesting as cavitary lesions in a critically ill elderly patient. J Infect Dev Ctries 2019;13(12):1170–1173. DOI: 10.3855/jidc.11265
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.